EGFR Signaling Networks in Cancer Therapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology
Cover of the book EGFR Signaling Networks in Cancer Therapy by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781597453561
Publisher: Humana Press Publication: March 1, 2009
Imprint: Humana Press Language: English
Author:
ISBN: 9781597453561
Publisher: Humana Press
Publication: March 1, 2009
Imprint: Humana Press
Language: English

The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies. Over decades of study, the EGF receptor structure, its ligand binding domains, the physical biochemistry underlying its intrinsic tyrosine kinase catalytic function and the modular interactions with SH2, PTB, and SH3 domain containing signaling adaptor p- teins required for signal transduction, have been extensively dissected. Not only is the EGF receptor the nexus of many streams of information, but it also forms one part of a calcul- ing device by forming dimers and oligomers with the other three receptors in its family in response to at least eleven ligands (some of which are expressed in multiple forms with overlapping or quite distinct functions). This phenomenon, while recruiting to the inner surface of the cell membrane and activating multiple second messenger proteins, also allows the possibility of cross talk between these systems, permitting a further layer of information to be exchanged. Less well described are the cross re gulation of the EGF receptor and other anti-apoptotic, mitogenic and metabolic signaling systems. The study of these systems has yielded new surprises. One hurdle in these efforts has been that signal transduction pathways have frequently been defined in the generic absence of their tissue-specific or cell-interaction specific context.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies. Over decades of study, the EGF receptor structure, its ligand binding domains, the physical biochemistry underlying its intrinsic tyrosine kinase catalytic function and the modular interactions with SH2, PTB, and SH3 domain containing signaling adaptor p- teins required for signal transduction, have been extensively dissected. Not only is the EGF receptor the nexus of many streams of information, but it also forms one part of a calcul- ing device by forming dimers and oligomers with the other three receptors in its family in response to at least eleven ligands (some of which are expressed in multiple forms with overlapping or quite distinct functions). This phenomenon, while recruiting to the inner surface of the cell membrane and activating multiple second messenger proteins, also allows the possibility of cross talk between these systems, permitting a further layer of information to be exchanged. Less well described are the cross re gulation of the EGF receptor and other anti-apoptotic, mitogenic and metabolic signaling systems. The study of these systems has yielded new surprises. One hurdle in these efforts has been that signal transduction pathways have frequently been defined in the generic absence of their tissue-specific or cell-interaction specific context.

More books from Humana Press

Cover of the book Drug Discovery and Development by
Cover of the book Allergic Diseases by
Cover of the book Seizures by
Cover of the book Complementary and Alternative Cardiovascular Medicine by
Cover of the book Cortical Sensory Organization by
Cover of the book The Police Composite Sketch by
Cover of the book Voiding Dysfunction by
Cover of the book Allogeneic Stem Cell Transplantation by
Cover of the book Hyperlipidemia in Primary Care by
Cover of the book Biosolids Engineering and Management by
Cover of the book Pulmonary Arterial Hypertension and Interstitial Lung Diseases by
Cover of the book Aging and Lung Disease by
Cover of the book Principles of Molecular Pathology by
Cover of the book BLyS Ligands and Receptors by
Cover of the book Immunoendocrinology: Scientific and Clinical Aspects by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy